L-Homoarginine and L-arginine are antagonistically related to blood pressure in an elderly population: The Hoorn study

Journal of Hypertension

Volumn 31, Issue 6, 2013, Pages 1114-1123

  Van Der Zwan, Leonard P ^a   Davids, Mariska ^a   Scheffer, Peter G ^a   Dekker, Jacqueline M ^a   Stehouwer, Coen D A ^b   Teerlink, Tom ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

asymmetric dimethylarginine; blood pressure; L arginine; L homoarginine; nitric oxide

Indexed keywords

ANTIHYPERTENSIVE AGENT; ARGININE; GLUCOSE; HOMOARGININE; LIPID; N(G),N(G) DIMETHYLARGININE; NITRIC OXIDE SYNTHASE;

AGED; AMINO ACID BLOOD LEVEL; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INFLAMMATION; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MICROALBUMINURIA; POPULATION BASED CASE CONTROL STUDY; PRIORITY JOURNAL; SMOKING; SYSTOLIC BLOOD PRESSURE;

EID: 84877579295     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32836037fb     Document Type: Article

References (43)

1. Cooke JP, Dzau VJ. Nitric oxide synthase: role in the genesis of vascular disease. Annu Rev Med 1997; 48:489-509.
2. Maxwell AJ. Mechanisms of dysfunction of the nitric oxide pathway in vascular diseases. Nitric Oxide 2002; 6:101-124.
3. Moncada S, Higgs EA. The discovery of nitric oxide and its role in vascular biology. Br J Pharmacol 2006; 147:S193-S201.
4. Chen PY, Sanders PW. L-arginine abrogates salt-sensitive hypertension in Dahl/Rapp rats. J Clin Invest 1991; 88:1559-1567.
5. Nakaki T, Hishikawa K, Suzuki H, Saruta T, Kato R. L-arginine-induced hypotension. Lancet 1990; 336:696.
6. Smulders RA, Aarsen M, Teerlink T, De Vries PM, Van Kamp GJ, Donker AJ, Stehouwer CD. Haemodynamic and biochemical responses to L-arginine and L-lysine infusions in normal subjects: L-arginineinduced vasodilatation cannot be explained by nonspecific effects of cationic amino acids. Clin Sci 1997; 92:367-374.
7. Dong JY, Qin LQ, Zhang Z, Zhao Y, Wang J, Arigoni F, Zhang W. Effect of oral L-arginine supplementation on blood pressure: a meta-analysis of randomized, double-blind, placebo-controlled trials. Am Heart J 2011; 162:959-965.
8. Hecker M, Walsh DT, Vane JR. On the substrate specificity of nitric oxide synthase. FEBS Lett 1991; 294:221-224.
9. Moali C, Boucher JL, Sari MA, Stuehr DJ, Mansuy D. Substrate specificity of NO synthases: detailed comparison of L-arginine, homo-L-arginine, their N omega-hydroxy derivatives, and N omega-hydroxynor-L-arginine. Biochemistry 1998; 37:10453-10460.
10. Chen PY, Sanders PW. Role of nitric oxide synthesis in salt-sensitive hypertension in Dahl/Rapp rats. Hypertension 1993; 22:812-818.
11. Achan V, Broadhead M, Malaki M, Whitley G, Leiper J, MacAllister R, Vallance P. Asymmetric dimethylarginine causes hypertension and cardiac dysfunction in humans and is actively metabolized by dimethylarginine dimethylaminohydrolase. Arterioscler Thromb Vasc Biol 2003; 23:1455-1459.
12. Kielstein JT, Impraim B, Simmel S, Bode-Böger SM, Tsikas D, Frölich JC, et al. Cardiovascular effects of systemic nitric oxide synthase inhibition with asymmetrical dimethylarginine in humans. Circulation 2004; 109:172-177.
13. Teerlink T, Luo Z, Palm F, Wilcox CS. Cellular ADMA: regulation and action. Pharmacol Res 2009; 60:448-460.
14. Böger RH, Sullivan LM, Schwedhelm E, Wang TJ, Maas R, Benjamin EJ, et al. Plasma asymmetric dimethylarginine and incidence of cardiovascular disease and death in the community. Circulation 2009; 119: 1592-1600.
15. Devés R, Boyd CA. Transporters for cationic amino acids in animal cells: discovery, structure, and function. Physiol Rev 1998; 78:487-545.
16. Closs EI, Boissel JP, Habermeier A, Rotmann A. Structure and function of cationic amino acid transporters (CATs). J Membr Biol 2006; 213: 67-77.
17. Bröer S, Palac?́n M. The role of amino acid transporters in inherited and acquired diseases. Biochem J 2011; 436:193-211.
18. Kakoki M, Kim HS, Edgell CJ, Maeda N, Smithies O, Mattson DL. Amino acids as modulators of endothelium-derived nitric oxide. Am J Physiol Renal Physiol 2006; 291:F297-F304.
19. Mooy JM, Grootenhuis PA, De Vries H, Valkenburg HA, Bouter LM, Kostense PJ, Heine RJ. Prevalence and determinants of glucose intolerance in a Dutch Caucasian population. The Hoorn study. Diabetes Care 1995; 18:1270-1273.
20. Spijkerman AM, Adriaanse MC, Dekker JM, Nijpels G, Stehouwer CD, Bouter LM, Heine RJ. Diabetic patients detected by population-based stepwise screening already have a diabetic cardiovascular risk profile. Diabetes Care 2002; 25:1784-1789.
21. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15:539-553.
22. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al. Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003; 42:1206-1252.
23. Teerlink T, Nijveldt RJ, De Jong S, Van Leeuwen PA. Determination of arginine, asymmetric dimethylarginine, and symmetric dimethylarginine in human plasma and other biological samples by high-performance liquid chromatography. Anal Biochem 2002; 303:131-137.
24. De Jong S, Teerlink T. Analysis of asymmetric dimethylarginine in plasma by HPLC using a monolithic column. Anal Biochem 2006; 353:287-289.
25. Scheffer PG, Van der Zwan LP, Schindhelm RK, Vermue HP, Teerlink T. Myeloperoxidase concentrations in EDTA-plasma of healthy subjects are discordant with concentrations in heparin-plasma and serum. Clin Biochem 2009; 42:1490-1492.
26. Grooteman MP, Gritters M, Wauters IM, Schalkwijk CG, Stam F, Twisk J, et al. Patient characteristics rather than the type of dialyser predict the variability of endothelial derived surface molecules in chronic haemodialysis patients. Nephrol Dial Transplant 2005; 20:2751-2758.
27. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate. Ann Intern Med 2006; 145:247-254.
28. Ryan WL, Wells IC. Homocitrulline and homoarginine synthesis from lysine. Science 1964; 144:1122-1127.
29. Kato T, Sano M, Mizutani N, Hayakawa C. Homocitrullinuria and homoargininuria in hyperargininaemia. J Inherit Metab Dis 1988; 11:261-265.
30. Derave W, Marescau B, Vanden Eede E, Eijnde BO, De Deyn PP, Hespel P. Plasma guanidino compounds are altered by oral creatine supplementation in healthy humans. J Appl Physiol 2004; 97:852-857.
31. Ryan WL, Johnson RJ, Dimari S. Homoarginine synthesis by rat kidney. Arch Biochem Biophys 1969; 131:521-526.
32. Srivenugopal KS, Adiga PR. Partial purification and properties of a transamidinase from Lathyrus sativus seedlings. Involvement in homoarginine metabolism and amine interconversions. Biochem J 1980; 189:553-560.
33. Davids M, Ndika JDT, Salomons GS, Blom HJ, Teerlink T. Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine. FEBS Lett 2012; 586:3653-3657.
34. Wyss M, Kaddurah-Daouk R. Creatine and creatinine metabolism. Physiol Rev 2000; 80:1107-1213.
35. Bell EA. Nonprotein amino acids of plants: significance in medicine, nutrition, and agriculture. J Agric Food Chem 2003; 51:2854-2865.
36. Rao SL. A look at the brighter facets of b-N-oxalyl-L-a,b- diaminopropionic acid, homoarginine and the grass pea. Food Chem Toxicol 2011; 49:620-622.
37. Valtonen P, Laitinen T, Lyyra-Laitinen T, Raitakari OT, Juonala M, Viikari JS, et al. Serum L-homoarginine concentration is elevated during normal pregnancy and is related to flow-mediated vasodilatation. Circ J 2008; 72:1879-1884.
38. März W, Meinitzer A, Drechsler C, Pilz S, Krane V, Kleber ME, et al. Homoarginine, cardiovascular risk, and mortality. Circulation 2010; 122:967-975.
39. Pilz S, Tomaschitz A, Meinitzer A, Drechsler C, Ritz E, Krane V, et al. Low serum homoarginine is a novel risk factor for fatal strokes in patients undergoing coronary angiography. Stroke 2011; 42:1132-1134.
40. Drechsler C, Meinitzer A, Pilz S, Krane V, Tomaschitz A, Ritz E, et al. Homoarginine, heart failure, and sudden cardiac death in haemodialysis patients. Eur J Heart Fail 2011; 13:852-859.
41. Lundberg JO, Weitzberg E, Gladwin MT. The nitrate-nitrite-nitric oxide pathway in physiology and therapeutics. Nat Rev Drug Discov 2008; 7:156-167.
42. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ 2009; 338:b1665.
43. Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 2002; 360:1903-1913.